Loading...
XSES8K7
Market cap55mUSD
Dec 20, Last price  
0.12SGD
1D
0.00%
1Q
-6.98%
Jan 2017
26.32%
IPO
63.64%
Name

UG Healthcare Corporation Ltd

Chart & Performance

D1W1MN
XSES:8K7 chart
P/E
—
P/S
0.65
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
1.47%
Rev. gr., 5y
4.67%
Revenues
115m
+13.91%
49,009,00055,740,00058,823,00065,239,00078,060,00091,712,000144,209,000338,401,000232,598,000101,133,000115,205,000
Net income
-6m
L-70.79%
4,900,0003,164,0005,450,0002,444,0004,335,0002,507,00013,402,000118,765,00036,795,000-20,734,000-6,056,000
CFO
-18m
L-53.62%
1,927,0001,983,000-1,405,000-7,105,000-402,000-6,367,00010,989,00081,162,00053,950,000-39,142,000-18,156,000
Dividend
Nov 17, 20220.0032 SGD/sh

Profile

UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. It operates through three segments: Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products. The company offers latex examination gloves that comprise single chlorinated and double chlorinated polymer coated gloves, as well as nitrile examination gloves. It also distributes ancillary products, including surgical gloves, vinyl and cleanroom disposable gloves, face masks, and other medical disposables, as well as shoe covers and other related products; and provides business and management consultancy services. The company's products are used in healthcare, food and beverage, industrial, high technology manufacturing, automotive, research and development, and beauty sectors. It serves customers under the Unigloves brand name in Malaysia, Europe, North America, South America, Africa, and rest of Asia. The company was founded in 1989 and is based in Singapore.
URL
https://www.ughealthcarecorporation.com/
IPO date
Dec 08, 2014
Employees
1,076
Domiciled in
MY
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
115,205
13.91%
101,133
-56.52%
232,598
-31.27%
Cost of revenue
121,833
126,252
181,432
Unusual Expense (Income)
NOPBT
(6,628)
(25,119)
51,166
NOPBT Margin
22.00%
Operating Taxes
(308)
(1,398)
8,963
Tax Rate
17.52%
NOPAT
(6,320)
(23,721)
42,203
Net income
(6,056)
-70.79%
(20,734)
-156.35%
36,795
-69.02%
Dividends
(3,992)
(1,211)
Dividend yield
4.44%
0.89%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
18,415
16,719
6,984
Long-term debt
26,183
15,003
12,519
Deferred revenue
Other long-term liabilities
Net debt
15,213
(37,084)
(87,158)
Cash flow
Cash from operating activities
(18,156)
(39,142)
53,950
CAPEX
(2,553)
(8,029)
(22,322)
Cash from investing activities
(22,732)
(8,029)
(21,194)
Cash from financing activities
8,362
8,698
(973)
FCF
(20,832)
(16,651)
23,094
Balance
Cash
27,998
61,745
100,218
Long term investments
1,387
7,061
6,443
Excess cash
23,625
63,749
95,031
Stockholders' equity
264,051
181,190
271,289
Invested Capital
181,371
146,913
152,446
ROIC
29.35%
ROCE
20.28%
EV
Common stock shares outstanding
623,826
623,826
620,198
Price
0.12
-16.67%
0.14
-34.55%
0.22
-61.74%
Market cap
74,859
-16.67%
89,831
-34.16%
136,444
-61.19%
EV
119,779
53,093
65,735
EBITDA
(2,756)
(21,645)
55,072
EV/EBITDA
1.19
Interest
1,282
915
805
Interest/NOPBT
1.57%